Freddy E Escorcia

Investigator, Lasker Clinical Research Scholar, Distinguished Scholar | Head, Laboratory of Molecular Radiotherapy

National Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Freddy E Escorcia is an Investigator and Lasker Clinical Research Scholar at the National Cancer Institute in the United States. He serves as the Head of the Laboratory of Molecular Radiotherapy. His research areas focus on advancements in radiation therapy, locoregional therapies for hepatocellular carcinoma, and the development of novel radiopharmaceutical therapies targeting solid tumors.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Hisataka Kobayashi

Chief Scientist/ Senoir Investigator

National Cancer Institute

UNITED STATES

View details

Deborah Citrin

National Cancer Institute

UNITED STATES

View details

Jaewhan Song

Professor

Yonsei University

SOUTH KOREA

View details

Joon-Yong Chung

National Cancer Institute

UNITED STATES

View details

Aki Furusawa

National Cancer Institute

UNITED STATES

View details

Hyunjin Rho

Yonsei University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Freddy E Escorcia

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Advances in radiation therapy for HCC: Integration with liver-directed treatments

Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid Tumors

Generation of Site‐Specifically Labeled Affinity Reagents via Use of a Self‐Labeling Single Domain Antibody

Meta‐analysis of randomized controlled trials of external‐beam radiation versus transarterial chemoembolization for hepatocellular carcinoma

Comparative Kidney Uptake of Nanobody-Based PET Tracers Labeled with Various Fluorine-18-Labeled Prosthetic Groups

Preparation of a Zirconium-89 Labeled Clickable DOTA Complex and Its Antibody Conjugate

Glypican-3 deficiency in liver cancer upregulates MAPK/ERK pathway but decreases cell proliferation

CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion

Locoregional Therapies for Hepatocellular Carcinoma

Prognostic significance of tertiary lymphoid structures in gastric neuroendocrine carcinoma with association to delta-like ligand 3 and neuroendocrine expressions

Near‐infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab‐IR700

Exploiting the DNA Damage Response for Prostate Cancer Therapy

Radiation Oncologists and Radiopharmaceutical Therapy: Strategies for Addressing Fair Compensation

Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Radiation Therapy Treatment Planning: A Review of PET Imaging Tracers and Methods to Incorporate PET/CT

Development of Iodinated Indocyanine Green Analogs as a Strategy for Targeted Therapy of Liver Cancer

Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model

Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET

Selective ablation of TRA-1-60<sup>+</sup> pluripotent stem cells suppresses tumor growth of prostate cancer

Collaborators (6)

Hisataka Kobayashi

Deborah Citrin

Jaewhan Song

Joon-Yong Chung

Aki Furusawa

Hyunjin Rho

Make your next move.